| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/23/2008 | CN101108243A Method of preparing traditional chinese medicine formulated product for treating rheumatism paralysis |
| 01/23/2008 | CN101108226A Medicament treating rheumatism, rheumatoid, woman's wind, osteoproliferation and slipped disc illness |
| 01/23/2008 | CN101108212A Pharmaceutical composition for treating paralysis |
| 01/23/2008 | CN101108210A Medicine for treating cervical vertebra disease |
| 01/23/2008 | CN101108205A Method of preparing ultramicro powder traditional Chinese medicine formulated product used for bone fracture convalescence period |
| 01/23/2008 | CN101108192A Phenols glycosides compounds with liveness against osteosporosis |
| 01/23/2008 | CN101108190A Application of cryptotanshinone in preparation of medicine preventing and controlling autoimmune disease |
| 01/23/2008 | CN100363365C Immunomodulating heterocyclic compounds |
| 01/23/2008 | CN100363362C Thiazole derivatives as NPY receptor antagonists |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363037C Medicine for treating rheumarthritis and traumatic injury pain and its prpen |
| 01/23/2008 | CN100363021C Use of cajan seed and its extract in preparing medicine for treating osteal arthritis |
| 01/23/2008 | CN100363019C Cervus and cucumis polypeptide injection composition and preparing method |
| 01/23/2008 | CN100363014C Gugua polypeptide medicinal composition for injetion and preparing method therefor |
| 01/22/2008 | US7321026 Framework-patched immunoglobulins |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320968 Pharmaceutical composition |
| 01/22/2008 | US7320873 for diagnosing autoimmune disease (rheumatoid arthritis) activity using monoclonal antibodies |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | CA2431515C Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2322967C Prophylactic, therapeutic agent for osteoporosis |
| 01/17/2008 | WO2008008493A2 Alkyne-substituted pyridone compounds and methods of use |
| 01/17/2008 | WO2008008474A2 Compositions and methods for the treatment of chronic pain conditions |
| 01/17/2008 | WO2008007880A1 A composition comprising an extract of prunus persica (l.) batsch for treating and preventing bone diseases |
| 01/17/2008 | WO2008007804A1 ANTIHUMAN α9 INTEGRIN ANTIBODY AND USE OF THE SAME |
| 01/17/2008 | WO2008007130A1 Furo [3,2-b] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 01/17/2008 | WO2008007127A1 Furo [3,2-b] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 01/17/2008 | WO2008007114A1 Tetrahydrofuro [3, 2 -b] pyrr0l-3-ones as cathepsin k inhibitors |
| 01/17/2008 | WO2008007112A1 Tetrahydrofuro [3, 2-b] pyrr0l-3-ones as cathepsin k inhibitors |
| 01/17/2008 | WO2008007109A1 Furo[3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 01/17/2008 | WO2008007107A1 Tetrahydrofuro (3, 2-b) pyrrol-3-one derivatives as inhibitors of cysteine proteinases |
| 01/17/2008 | WO2008006607A2 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 01/17/2008 | WO2008006589A2 Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 01/17/2008 | WO2008006582A1 Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases |
| 01/17/2008 | WO2008006581A2 Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders |
| 01/17/2008 | WO2008006216A1 Anti-inflammatory and cytoprotectant chronotherapy |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007084853A3 Methods for inhibiting osteoclastogenesis |
| 01/17/2008 | US20080015247 quercetin, vitamin B3, and vitamin C as only ingredients, specified weight ratio; dietary supplement or a pharmaceutical formulation; free radical induced diseases |
| 01/17/2008 | US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015204 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015177 S1P receptor modulating compounds and use thereof |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015173 Estrogen Receptor Modulators |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080014279 adding bioactive particles consisting of bioactive glass to solution comprising at least one high molecular weight biodegradable polymer, precipitating the polymer, thereby forming bioactive particles individually microencapsulated coated with high molecular weight polymer such as porcine gelatin |
| 01/17/2008 | US20080014272 Compositions and Methods for Treatment of Chronic Pain Conditions |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | DE102006031813A1 Basische Acetophenone als Hemmstoffe von NO-Synthasen Basic acetophenones as inhibitors of NO synthases |
| 01/17/2008 | CA2658241A1 Scfv antibodies which pass epithelial and/or endothelial layers |
| 01/17/2008 | CA2657816A1 Tetrahydrofuro [3, 2 -b] pyrr0l-3-ones as cathepsin k inhibitors |
| 01/17/2008 | CA2657748A1 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 01/17/2008 | CA2657308A1 Treatment of excessive neovascularization |
| 01/17/2008 | CA2657133A1 Anti-human .alpha.9 integrin antibody and use of the same |
| 01/17/2008 | CA2655202A1 Glucocorticoid receptor modulator and methods of use |
| 01/17/2008 | CA2551163A1 Methods for treating inflammatory, autoimmune or bone resorption diseases |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878429A1 Trenadermal absorption preparation |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1877069A2 Novel use of spiegelmers |
| 01/16/2008 | EP1625126B1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | CN101107252A Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases |
| 01/16/2008 | CN101107005A CRIg polypeptide for prevention and treatment of complement-associated disorders |
| 01/16/2008 | CN101104036A Traditional Chinese medicinal liquid for treating rheumatic arthritis and rheumatoid arthritis |
| 01/16/2008 | CN101104035A Medicine composition for treating hyperosteogeny disease and preparation method |
| 01/16/2008 | CN101104009A Angelica polymorpha extract and its medicinal use |
| 01/16/2008 | CN101104004A Medicine for treating hyperosteogeny and rheumatic arthritis and its preparing method |
| 01/16/2008 | CN101103999A Bone peptide injection preparation technology |
| 01/16/2008 | CN101103994A Medicine for preventing and treating gout and hyperuricemia |
| 01/16/2008 | CN101103974A New application of dendrobine |
| 01/16/2008 | CN101103872A Cervical vertebra recovering pillow |
| 01/16/2008 | CN100361655C (-)-epigallocatechin gallate-calcium complex solid dispersion and its prepn and application |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 01/15/2008 | US7319102 Pyrrolo[2,3-d]pyrimidine cytokine inhibitors |
| 01/15/2008 | US7318840 Intervertebral disc treatment devices and methods |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2296769C Modified dorsal tissue affecting factor and compositions |
| 01/10/2008 | WO2008006118A2 Novel regimens for treating diseases and disorders |
| 01/10/2008 | WO2008006117A2 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 01/10/2008 | WO2008006106A2 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 01/10/2008 | WO2008006044A2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |